Enliven Therapeutics shares owned by Rockefeller Capital Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Rockefeller Capital Management
from 13F filings
Historical chart of Rockefeller Capital Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Enliven Therapeutics by Rockefeller Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $980 | 25 | 39.20 |
More positions owned by Rockefeller Capital Management
View all positions for Rockefeller Capital Management